5 Essential Elements For Sulfoxaflor
All enrolled patients who obtained at the least a person dose of zosuquidar or placebo all through induction have been monitored for that prevalence of adverse activities (439 clients, 219 on zosuquidar and 210 on placebo). The commonest adverse events had been relevant to the duration of prolonged and substantial myelosuppression as is anticipated